Alector Inc (ALEC)
4.92
+0.11
(+2.29%)
USD |
NASDAQ |
Sep 27, 16:00
4.94
+0.02
(+0.41%)
After-Hours: 20:00
Alector SG&A Expense (TTM): 57.09M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 57.09M |
March 31, 2024 | 56.34M |
December 31, 2023 | 56.69M |
September 30, 2023 | 57.15M |
June 30, 2023 | 58.04M |
March 31, 2023 | 60.26M |
December 31, 2022 | 61.03M |
September 30, 2022 | 62.58M |
June 30, 2022 | 61.35M |
March 31, 2022 | 59.58M |
December 31, 2021 | 55.04M |
September 30, 2021 | 51.33M |
Date | Value |
---|---|
June 30, 2021 | 54.15M |
March 31, 2021 | 55.77M |
December 31, 2020 | 59.40M |
September 30, 2020 | 58.76M |
June 30, 2020 | 51.25M |
March 31, 2020 | 43.98M |
December 31, 2019 | 35.10M |
September 30, 2019 | 26.58M |
June 30, 2019 | 21.18M |
March 31, 2019 | 15.27M |
December 31, 2018 | 11.93M |
September 30, 2018 | 9.897M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
26.58M
Minimum
Sep 2019
62.58M
Maximum
Sep 2022
54.07M
Average
56.89M
Median
SG&A Expense (TTM) Benchmarks
Omeros Corp | 53.37M |
Nuwellis Inc | 14.88M |
Harrow Inc | 107.88M |
Amphastar Pharmaceuticals Inc | 88.15M |
PetIQ Inc | 208.04M |